There is insufficient evidence of carcinogenicity of eszopiclone tablets and eszopiclone tablets should not be abused.
Although eszopiclone was once recognized as a group 3 carcinogen by the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO), there is insufficient evidence of its carcinogenicity to humans and animals, and there is no direct evidence that eszopiclone causes cancer.
Eszopiclone tablets are psychotropic drugs, which have the effect of treating insomnia, anti-anxiety, anti-epilepsy, and anticonvulsant.
The use of eszopiclone tablets may bring about adverse reactions such as allergy, dry mouth, generalized weakness, drowsiness, dizziness, and respiratory depression. It is forbidden for those who are allergic to eszopiclum tablets and benzodiazepines, pregnant women, patients with acute angle-closure glaucoma, those with myasthenia gravis, and patients with hepatic or renal insufficiency.
It is recommended to take eszopiclone tablets need to be guided by a doctor, and should not be used arbitrarily.